Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Ethyl Acetate | HCID 8857 | — |
| Reactant | Sodium borohydride | HCID 4311764 | — |
| Reactant | HCID 69040616 | HCID 69040616 | — |
| Solvent | Ethyl orthoformate | HCID 31214 | — |
| Solvent | Sodium chloride; water | HCID 57417360 | — |
| Product | HCID 69041919 | HCID 69041919 | — |
Reaction Steps
A suspension of 1-[1-(3,4-dichloro-phenyl)-1H-imidazol-4-ylmethyl]-1H-imidazol-2-ylamine (0.7 g, 2.3 mmol) in triethyl orthoformate (10 ml) was stirred under reflux for 2 h. The reaction mixture was evaporated to dryness, dissolved in ethanol (10 ml) and cooled in an ice bath. Sodium borohydride (0.091 g, 2.4 mmol) was added and the mixture was allowed to slowly reach 20° C. After 18 h AcOEt and brine was added and the organic phase was separated, dried (Na2SO4) and concentrated. After chromatography [silica, elution with gradient CH2Cl2 to 100% (CH2Cl2/MeOH/aq. NH4OH=90:10:1)] the free base of the title compound was obtained. It was crystallized as the off-white hydrochloride salt (0.25 g; 16%). Mp. >250° C. (MeOH/Et2O), MS: m/e=322 (M+H+).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US06667335B2 |
|---|
| Source dataset | uspto-grants-2003_12 |
|---|
| ORD ID | ord-af40f3f0dda44c8bb69ffe21e1dbf6ad |
|---|
| Source note | uspto-grants-2003_12 |
|---|